StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories common Shares Repurchased — Value ($M) ($M)

Form 10-K / 10-Q Stockholders' Equity Footnote

Latest, FY2025
629
Period ended Dec 31, 2025
Change on a year earlier
-45.0%
1,143 in FY2024
History
12 years
Since FY2014
Sources
10
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCommon Shares Repurchased — Value ($M) ($M)Year on yearSource
FY2025Dec 31, 2025629-45.0%SEC Filing (0001628280-26-010185) ↗
FY2024Dec 31, 20241,143+9.0%SEC Filing (0001628280-26-010185) ↗
FY2023Dec 31, 20231,049-71.5%SEC Filing (0001628280-26-010185) ↗
FY2022Dec 31, 20223,676+79.2%SEC Filing (0001628280-25-007110) ↗
FY2021Dec 31, 20212,051+962.7%SEC Filing (0001628280-24-005348) ↗
FY2020Dec 31, 2020193-64.7%SEC Filing (0001628280-23-004026) ↗
FY2019Dec 31, 2019546+276.6%SEC Filing (0001104659-22-025141) ↗
FY2018Dec 31, 2018145+935.7%SEC Filing (0001104659-21-025751) ↗
FY2017Dec 31, 201714-96.7%SEC Filing (0001104659-20-023904) ↗
FY2016Dec 31, 2016419-80.9%SEC Filing (0001047469-19-000624) ↗
FY2015Dec 31, 20152,194+3.6%SEC Filing (0001047469-18-000856) ↗
FY2014Dec 31, 20142,117–SEC Filing (0001047469-17-000744) ↗

Breakdown

What makes up common shares repurchased — value ($m)

Cite this data

StockData. (2026). Abbott Laboratories Common Shares Repurchased — Value ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/xbrl-buyback-val

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.